Overall, we developed a targeted and pH-sensitive DDS based on EpCAM Apt-functionalized MSNs, which can successfully deliver 5-FU to CRC cells and enhance anti-cancer activity, while reducing systemic off-target toxicities. This evidence concerns the gene EPCAM and colorectal carcinoma.